SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kayode Ogungbenro, Leon Aarons, Physiologically based pharmacokinetic model for 6-mercpatopurine: exploring the role of genetic polymorphism in TPMT enzyme activity, British Journal of Clinical Pharmacology, 2015, 80, 1
  2. 2
    Tuğçe Tülümen, Ali Ayata, Metehan Özen, Recep Sütçü, Duran Canatan, The Protective Effect of Capparis ovata on 6-Mercaptopurine-induced Hepatotoxicity and Oxidative Stress in Rats, Journal of Pediatric Hematology/Oncology, 2015, 37, 4, 290

    CrossRef

  3. 3
    Kjeld Schmiegelow, Stine N. Nielsen, Thomas L. Frandsen, Jacob Nersting, Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia, Journal of Pediatric Hematology/Oncology, 2014, 36, 7, 503

    CrossRef

  4. 4
    B L Fridley, G D Jenkins, A Batzler, L Wang, Y Ji, F Li, R M Weinshilboum, Multivariate models to detect genomic signatures for a class of drugs: application to thiopurines pharmacogenomics, The Pharmacogenomics Journal, 2012, 12, 2, 105

    CrossRef

  5. 5
    Xiang Gao, Fang-bin Zhang, Liang Ding, Hui Liu, Xue-ding Wang, Bai-li Chen, Hui-chang Bi, Ying-Lian Xiao, Li-zi Zhao, Min-hu Chen, Min Huang, Pin-jin Hu, The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients, European Journal of Gastroenterology & Hepatology, 2012, 24, 8, 958

    CrossRef

  6. 6
    Malin Lindqvist Appell, Patricia Wennerstrand, Curt Peterson, Erik Hertervig, Lars-Göran Mårtensson, Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene, Pharmacogenetics and Genomics, 2010, 20, 11, 700

    CrossRef

  7. 7
    Liewei Wang, Pharmacogenomics: a systems approach, Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 2010, 2, 1
  8. 8
    Sarah L. Noble, Eric Sherer, Robert E. Hannemann, Doraiswami Ramkrishna, Terry Vik, Ann E. Rundell, Using adaptive model predictive control to customize maintenance therapy chemotherapeutic dosing for childhood acute lymphoblastic leukemia, Journal of Theoretical Biology, 2010, 264, 3, 990

    CrossRef

  9. 9
    Xue-Qun Luo, Zhi-Yong Ke, Li-Bin Huang, Xiao-Qing Guan, Xiao-Li Zhang, Jia Zhu, Ying-Chuang Zhang, Maintenance therapy with dose-adjusted 6-mercaptopurine in idiopathic pulmonary hemosiderosis, Pediatric Pulmonology, 2008, 43, 11
  10. 10
    Gemma Molyneux, Frances M. Gibson, Christabelle M. Chen, Harpal K. Marway, Sean McKeag, Charles V. J. Mifsud, Andrew M. Pilling, Matthew J. Whayman, John A. Turton, The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse, International Journal of Experimental Pathology, 2008, 89, 2
  11. 11
    Taieb Jomni, Xavier Dray, Philippe Marteau, Pourquoi et comment associer les analogues des bases puriques et les aminosalicylés au cours des MICI ?, Gastroentérologie Clinique et Biologique, 2007, 31, 8-9, 758

    CrossRef

  12. 12
    Scott Hande, Noah Wilson-Rich, Athos Bousvaros, Anna Zholudev, Rie Maurer, Peter Banks, Frederick Makrauer, Sarathchandra Reddy, Robert Burakoff, Sonia Friedman, 5-Aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine, Inflammatory Bowel Diseases, 2006, 12, 4
  13. 13
    Kersti Oselin, Kaili Anier, Riin Tamm, Kristi Kallassalu, Uno Mäeorg, Determination of thiopurine S-methyltransferase (TPMT) activity by comparing various normalization factors: Reference values for Estonian population using HPLC-UV assay, Journal of Chromatography B, 2006, 834, 1-2, 77

    CrossRef

  14. 14
    L Wang, R Weinshilboum, Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions, Oncogene, 2006, 25, 11, 1629

    CrossRef

  15. 15
    Emmett H. Broxson, Mukund Dole, Raymond Wong, Bernard F. Laya, Linda Stork, Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy, Pediatric Blood & Cancer, 2005, 44, 3
  16. 16
    Dana Kazlow Stern, Jackie M. Tripp, Vincent C. Ho, Mark Lebwohl, The Use of Systemic Immune Moderators in Dermatology: An Update, Dermatologic Clinics, 2005, 23, 2, 259

    CrossRef

  17. 17
    Herlinde Dumez, Walter H. Reinhart, Gunther Guetens, Ernst A. de Bruijn, Human Red Blood Cells: Rheological Aspects, Uptake, and Release of Cytotoxic Drugs, Critical Reviews in Clinical Laboratory Sciences, 2004, 41, 2, 159

    CrossRef

  18. 18
    Gwo-Tzer Ho, Charlie Lees, Jack Satsangi, Pharmacogenetics and inflammatory bowel disease: Progress and Prospects, Inflammatory Bowel Diseases, 2004, 10, 2
  19. 19
    William J. Sandborn, Pharmacogenomics and IBD. TPMT and thiopurines, Inflammatory Bowel Diseases, 2004, 10, 7
  20. 20
    Chinyu Su, Gary R Lichtenstein, Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine, Gastroenterology Clinics of North America, 2004, 33, 2, 209

    CrossRef

  21. 21
    Gary R. Lichtenstein, Use of laboratory testing to guide 6-mercaptopurine/azathioprine therapy, Gastroenterology, 2004, 127, 5, 1558

    CrossRef

  22. 22
    Georg Hempel, Drug Monitoring and Clinical Chemistry, 2004,

    CrossRef

  23. 23
    Carlton W. Thomas, Philip W. Lowry, Curtis L. Franklin, Amy L. Weaver, Gennett M. Myhre, Dennis C. Mays, William J. Tremaine, James J. Lipsky, William J. Sandborn, Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine, Inflammatory Bowel Diseases, 2003, 9, 4
  24. 24
    Marla C. Dubinsky, Johanna C. Escher, Monitoring of AZA/6-MP treatment in children with IBD is necessary, Inflammatory Bowel Diseases, 2003, 9, 6
  25. 25
    Marla C. Dubinsky, Optimizing immunomodulator therapy for inflammatory bowel disease, Current Gastroenterology Reports, 2003, 5, 6, 506

    CrossRef

  26. 26
    Niraj Jani, Miguel D Regueiro, Medical therapy for ulcerative colitis, Gastroenterology Clinics of North America, 2002, 31, 1, 147

    CrossRef

  27. 27
    G. Belgi, P. S. Friedmann, Traditional therapies: glucocorticoids, azathioprine, methotrexate, hydroxyurea, Clinical and Experimental Dermatology, 2002, 27, 7
  28. 28
    Marla C. Dubinsky, Philip V. Hassard, Ernest G. Seidman, Lori Y. Kam, Maria T. Abreu, Stephan R. Targan, Eric A. Vasiliauskas, An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy, Inflammatory Bowel Diseases, 2001, 7, 3
  29. 29
    M.Gennett Pike, Curtis L. Franklin, Dennis C. Mays, James J. Lipsky, Philip W. Lowry, William J. Sandborn, Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood, Journal of Chromatography B: Biomedical Sciences and Applications, 2001, 757, 1, 1

    CrossRef

  30. 30
    William E. Evans, Pharmacodynamics of cancer chemotherapy: childhood ALL as a model, International Congress Series, 2001, 1220, 203

    CrossRef

  31. 31
    C.G. Su, R.B. Stein, J.D. Lewis, G.R. Lichtenstein, Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?, Digestive and Liver Disease, 2000, 32, 6, 518

    CrossRef

  32. 32
    William J. Sandborn, William A. Faubion, Clinical pharmacology of inflammatory bowel disease therapies, Current Gastroenterology Reports, 2000, 2, 6, 440

    CrossRef

  33. 33
    C. Cuffari, S. Hunt, T. M. Bayless, Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy, Alimentary Pharmacology & Therapeutics, 2000, 14, 8
  34. 34
    Marla C. Dubinsky, Stéphanie Lamothe, Hui Ying Yang, Stephan R. Targan, Daniel Sinnett, Yves Théorêt, Ernest G. Seidman, Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease, Gastroenterology, 2000, 118, 4, 705

    CrossRef

  35. 35
    Federico Innocenti, Romano Danesi, Claudio Favre, Margherita Nardi, Maria Christina Menconi, Antonello Di Paolo, Guido Bocci, Stefano Fogli, Cecilia Barbara, Serena Barachini, Gabriella Casazza, Pierantonio Macchia, Mario Del Tacca, Variable Correlation Between 6-Mercaptopurine Metabolites in Erythrocytes and Hematologic Toxicity: Implications for Drug Monitoring in Children With Acute Lymphoblastic Leukemia, Therapeutic Drug Monitoring, 2000, 22, 4, 375

    CrossRef

  36. 36
    F. M. Balis, P. C. Adamson, Application of Pharmacogenetics to Optimization of Mercaptopurine Dosing, JNCI Journal of the National Cancer Institute, 1999, 91, 23, 1983

    CrossRef

  37. 37
    William J. Sandborn, William J. Tremaine, Douglas C. Wolf, Stephan R. Targan, Charles A. Sninsky, Lloyd R. Sutherland, Stephen B. Hanauer, John W.D. McDonald, Brian G. Feagan, Richard N. Fedorak, Kim L. Isaacs, M.Gennette Pike, Dennis C. Mays, James J. Lipsky, Susan Gordon, Christi S. Kleoudis, Robert H. Murdock, Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease, Gastroenterology, 1999, 117, 3, 527

    CrossRef

  38. 38
    Maria Chrzanowska, Pawel Kolecki, Barbara Duczmal-Cichocka, Joanna Fiet, Metabolites of mercaptopurine in red blood cells: a relationship between 6-thioguanine nucleotides and 6-methylmercaptopurine metabolite concentrations in children with lymphoblastic leukemia, European Journal of Pharmaceutical Sciences, 1999, 8, 4, 329

    CrossRef

  39. 39
    Jan P. Dutz, Vincent C. Ho, IMMUNOSUPPRESSIVE AGENTS IN DERMATOLOGY, Dermatologic Clinics, 1998, 16, 2, 235

    CrossRef

  40. 40
    Lancaster, Lennard, Rowland, Vora, Lilleyman, Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations, British Journal of Haematology, 1998, 102, 2
  41. 41
    Matitiahu Berkovitch, Doreen Matsui, Alvin Zipursky, Victor S. Blanchette, Zul Verjee, Esther Giesbrecht, Earl F. Saunders, William E. Evans, Gideon Koren, Hepatotoxicity of 6-mercaptopurine in childhood acute lymphocytic leukemia: Pharmacokinetic characteristics, Medical and Pediatric Oncology, 1996, 26, 2
  42. 42
    C.W. Keuzenkamp-Jansen, P.A.J. Leegwater, R.A. De Abreu, M.A.H. Lambooy, J.P.M. Bökkerink, J.M.F. Trijbels, Thiopurine methyltransferase: a review and a clinical pilot study, Journal of Chromatography B: Biomedical Sciences and Applications, 1996, 678, 1, 15

    CrossRef

  43. 43
    John L Snow, Lawrence E Gibson, A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients, Journal of the American Academy of Dermatology, 1995, 32, 1, 114

    CrossRef

  44. 44
    William J. Sandborn, Erik C. Van Os, Bradley J. Zins, William J. Tremaine, Dennis C. Mays, James J. Lipsky, An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease, Gastroenterology, 1995, 109, 6, 1808

    CrossRef

  45. 45
    A. Rostami-Hodjegan, L. Lennard, JS Lilleyman, The accumulation of mercaptopurine metabolites in age fractionated red blood cells., British Journal of Clinical Pharmacology, 1995, 40, 3
  46. 46
    D. Gail May, Genetic Differences in Drug Disposition, The Journal of Clinical Pharmacology, 1994, 34, 9
  47. 47
    Jon A. Van Loon, Carol L. Szumlanski, Richard M. Weinshilboum, Human kidney thiopurine methyltransferase, Biochemical Pharmacology, 1992, 44, 4, 775

    CrossRef

  48. 48
    R. M. Weinshilboum, Methylation pharmacogenetics: Thiopurine methyltransferase as a model system, Xenobiotica, 1992, 22, 9-10, 1055

    CrossRef

  49. 49
    William E. Evans, Michelle Horner, Ya Qin Chu, David Kalwinsky, W. Mark Roberts, Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia, The Journal of Pediatrics, 1991, 119, 6, 985

    CrossRef

  50. 50
    Robert L. Capizzi, J. Courtland White, Daniel J. Fernandes, Antimetabolites, Baillière's Clinical Haematology, 1991, 4, 1, 15

    CrossRef

  51. 51
    Jan Liliemark, Birgitta Pettersson, MÅRten Järnmark, Curt Peterson, On the Cellular Pharmacokinetics of 6-Thioguanine in Acute Myelogenous Leukemia, Leukemia & Lymphoma, 1991, 4, 4, 271

    CrossRef

  52. 52
    J. S. Lilleyman, Variables and Paradoxes in “Maintenance” Therapy of Lymphoblastic Leukemia, Pediatric Hematology and Oncology, 1991, 8, 4, ix

    CrossRef

  53. 53
    Kjeld Schmiegelow, Ivan Bruunshuus, 6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia, Cancer Chemotherapy and Pharmacology, 1990, 26, 4, 288

    CrossRef

  54. 54
    Gary R. Erdmann, Laura A. France, Bruce C. Bostrom, Daniel M. Canafax, A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in a patient receiving thiopurine therapy, Biomedical Chromatography, 1990, 4, 2
  55. 55
    Gary L. C. Chan, Gary R. Erdmann, Scott A. Gruber, Arthur J. Matas, Daniel M. Canafax, Azathioprine Metabolism: Pharmacokinetics of 6-Mercaptopurine, 6-Thiouric Acid and 6-Thioguanine Nucleotides in Renal Transplant Patients, The Journal of Clinical Pharmacology, 1990, 30, 4
  56. 56
    L. Lennard, J.S. Lilleyman, J. Van Loon, R.M. Weinshilboum, Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia, The Lancet, 1990, 336, 8709, 225

    CrossRef

  57. 57
    G.M. MURPHY, P.D.L. MAURICE, P.G. NORRIS, R.W. MORRIS, J.L.M. HAWK, Azathioprine treatment in chronic actinic dermatitis: a double-blind controlled trial with monitoring of exposure to ultraviolet radiation, British Journal of Dermatology, 1989, 121, 5
  58. 58
    Richard Weinshilboum, Methyltransferase pharmacogenetics, Pharmacology & Therapeutics, 1989, 43, 1, 77

    CrossRef

  59. 59
    T. TRNOVEC, Z. KÁLLAY, Determination of Beta-Blockers in Biological Material, 1989,

    CrossRef

  60. 60
    William E. Evans, Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity, Blut, 1988, 56, 6, 241

    CrossRef

  61. 61
    Richard Weinshilboum, Pharmacogenetics of methylation: Relationship to drug metabolism, Clinical Biochemistry, 1988, 21, 4, 201

    CrossRef

  62. 62
    L. Lennard, J.S. Lilleyman, ARE CHILDREN WITH LYMPHOBLASTIC LEUKAEMIA GIVEN ENOUGH 6-MERCAPTOPURINE?, The Lancet, 1987, 330, 8562, 785

    CrossRef

  63. 63
    Lynne Lennard, Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells, Journal of Chromatography B: Biomedical Sciences and Applications, 1987, 423, 169

    CrossRef

  64. 64
    L Lennard, CI Harrington, M Wood, JL Maddocks, Metabolism of azathioprine to 6-thioguanine nucleotides in patients with pemphigus vulgaris., British Journal of Clinical Pharmacology, 1987, 23, 2
  65. 65
    Richard Weinshilboum, Pharmacogenetics of methyl conjugation and thiopurine drug toxicity, BioEssays, 1987, 7, 2
  66. 66
    Gary L. C. Chan, Daniel M. Canafax, Curtis A. Johnson, The Therapeutic Use of Azathioprine in Renal Transplantation, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1987, 7, 5
  67. 67
    J.L. Maddocks, Lynne Lennard, J. Amess, R. Amos, R. Meyrick Thomas, AZATHIOPRINE AND SEVERE BONE MARROW DEPRESSION, The Lancet, 1986, 327, 8473, 156

    CrossRef

  68. 68
    Gudmar Lönnerholm, Anders Kreuger, Björn Lindström, Jonny Ludvigsson, Urban Myrdal, Plasma and Erythrocyte Concentrations of Mercaptopurine after Oral Administration in Children, Pediatric Hematology and Oncology, 1986, 3, 1, 27

    CrossRef

  69. 69
    Jos P.M. Bökkerink, Marinka A.H. Bakker, Tilly W. Hulscher, Ronney R.A. De Abreu, Egbert D.A.M. Schretlen, Jan P.R.M. Van Laarhoven, Chris H.M.M. De Bruyn, Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts, Biochemical Pharmacology, 1986, 35, 20, 3549

    CrossRef

  70. 70
    Lawrence E. Lavi, John S. Holcenberg, A rapid and sensitive high-performance liquid chromatographic assay for 6-mercaptopurine metabolites in red blood cells, Analytical Biochemistry, 1985, 144, 2, 514

    CrossRef

  71. 71
    L. Lennard, Assay of 6-mercaptopurine in human plasma, Journal of Chromatography B: Biomedical Sciences and Applications, 1985, 345, 441

    CrossRef

  72. 72
    L. LENNARD, S. THOMAS, C.I. HARRINGTON, J.L. MADDOCKS, Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cells, British Journal of Dermatology, 1985, 113, 6
  73. 73
    L Lennard, CB Brown, M Fox, JL Maddocks, Azathioprine metabolism in kidney transplant recipients., British Journal of Clinical Pharmacology, 1984, 18, 5
  74. 74
    L Lennard, MF Murphy, JL Maddocks, Severe megaloblastic anaemia associated with abnormal azathioprine metabolism., British Journal of Clinical Pharmacology, 1984, 17, 2
  75. 75
    L Lennard, CA Rees, JS Lilleyman, JL Maddocks, Childhood leukaemia: a relationship between intracellular 6- mercaptopurine metabolites and neutropenia., British Journal of Clinical Pharmacology, 1983, 16, 4
  76. 76
    Nilesh Chande, David J Tsoulis, John K MacDonald, Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease, The Cochrane Library,
  77. 77
    William J Sandborn, Lloyd R Sutherland, David Pearson, Gary May, Robert Modigliani, Cosimo Prantera, Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease, The Cochrane Library,
  78. 78
    Eliza Prefontaine, John K MacDonald, Lloyd R Sutherland, Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease, The Cochrane Library,
  79. 79
    Eliza Prefontaine, John K MacDonald, Lloyd R Sutherland, Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease, The Cochrane Library,
  80. 80
    Richard Weinshilboum, Thiopurine S-Methyltransferase, Encyclopedia Of Molecular Medicine,
  81. 81
    Fang Li, Richard M. Weinshilboum, Thiopurine S-Methyltransferase Pharmacogenomics: Protein Misfolding, Aggregation, and Degradation,